Close Menu

NEW YORK (GenomeWeb) – Biocept reported after the close of the market on Wednesday that its first quarter revenues increased 27 percent year over year.

For the three months ended March 31, the San Diego-based liquid biopsy firm saw $1.0 million in revenues compared to $806,943 a year ago. These included about $976,000 in commercial test revenues and $42,000 from development services testing. The firm posted $6,000 in other revenues.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.